- 5-(Thiophen-2-ylmethoxy)-AMT
- 5-(Thiophen-2-ylmethoxy)-α-methyltryptamine
- BW-723C86
- 1-{5-[(Thiophen-2-yl)methoxy]-1H-indol-3-yl}propan-2-amine
- 1-[5-(Thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine
Schumacher, M. Chirale arylmethoxytryptamine als 5-HT2B-Rezeptoragonisten: synthese, analytik und in-vitro-pharmakologie Ph. D. Thesis, Universität Regensburg, Würzburg, Germany, 16 Mar 2007. 2.2 MB. #111 In German. MS,NMR,other
DuPre, A. BW723C86 In xPharm: The Comprehensive Pharmacology Reference; Enna, SJ; Bylund, DB, Eds., Elsevier, 1 Jan 2007; pp 1–6. 1.3 MB. https://doi.org/10.1016/B978-008055232-3.61362-5 #BW723C86
Currie, KS. Antianxiety Agents In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #119
Flanagan, TW; Billac, GB; Landry, AN; Sebastian, MN; Cormier, SA; Nichols, CD. Structure–activity relationship analysis of psychedelics in a rat model of asthma reveals the anti-inflammatory pharmacophore ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 488-502. 13.3 MB. https://doi.org/10.1021/acsptsci.0c00063 #BW723C86